Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Return on Sales (2018 - 2025)

Health Catalyst (HCAT) has disclosed Return on Sales for 8 consecutive years, with 0.29% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales fell 10.0% year-over-year to 0.29%, compared with a TTM value of 0.34% through Sep 2025, down 8.0%, and an annual FY2024 reading of 0.23%, up 17.0% over the prior year.
  • Return on Sales was 0.29% for Q3 2025 at Health Catalyst, up from 0.51% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.18% in Q2 2024 and bottomed at 0.76% in Q4 2021.
  • Average Return on Sales over 5 years is 0.43%, with a median of 0.45% recorded in 2023.
  • The sharpest move saw Return on Sales skyrocketed 37bps in 2023, then plummeted -33bps in 2025.
  • Year by year, Return on Sales stood at 0.76% in 2021, then soared by 32bps to 0.52% in 2022, then increased by 22bps to 0.4% in 2023, then skyrocketed by 36bps to 0.26% in 2024, then fell by -12bps to 0.29% in 2025.
  • Business Quant data shows Return on Sales for HCAT at 0.29% in Q3 2025, 0.51% in Q2 2025, and 0.3% in Q1 2025.